Free Trial
OTCMKTS:CBDS

Cannabis Sativa (CBDS) Stock Price, News & Analysis

Cannabis Sativa logo
$0.04 +0.00 (+1.27%)
As of 03:57 PM Eastern

About Cannabis Sativa Stock (OTCMKTS:CBDS)

Key Stats

Today's Range
$0.03
$0.04
50-Day Range
$0.04
$0.08
52-Week Range
$0.00
$0.17
Volume
510,469 shs
Average Volume
1.44 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.

Remove Ads

Cannabis Sativa Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

CBDS MarketRank™: 

Cannabis Sativa scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Cannabis Sativa.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cannabis Sativa is -0.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cannabis Sativa is -0.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Cannabis Sativa has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cannabis Sativa has recently increased by 373.13%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cannabis Sativa does not currently pay a dividend.

  • Dividend Growth

    Cannabis Sativa does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Cannabis Sativa has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cannabis Sativa has recently increased by 373.13%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Cannabis Sativa has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Cannabis Sativa this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Cannabis Sativa insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    27.46% of the stock of Cannabis Sativa is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Cannabis Sativa's insider trading history.
Receive CBDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cannabis Sativa and its competitors with MarketBeat's FREE daily newsletter.

CBDS Stock News Headlines

Cannabis Sativa Delays Form 10-K Filing
Elon Warns: Exec Order 14024 Targets Dollar
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.
See More Headlines

CBDS Stock Analysis - Frequently Asked Questions

Cannabis Sativa's stock was trading at $0.0870 at the beginning of 2025. Since then, CBDS stock has decreased by 54.0% and is now trading at $0.04.
View the best growth stocks for 2025 here
.

Shares of CBDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cannabis Sativa investors own include Canopy Growth (CGC), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Cara Therapeutics (CARA), 22nd Century Group (XXII) and Sangamo Therapeutics (SGMO).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Health Information Services
Sub-Industry
Cannabis
Current Symbol
OTCMKTS:CBDS
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report

This page (OTCMKTS:CBDS) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners